Influence of percutaneous pulmonary valve implantation on exercise capacity: Which group of patients benefits most from the intervention?

Autor: Mirosław Kowalski, Mateusz Śpiewak, Ewa Piotrowicz, Aneta Fronczak, Marcin Demkow, Witold Rużyłło, Magdalena Mazgaj, Piotr Hoffman, Krzysztof Weroński, Ryszard Piotrowicz, Elżbieta Katarzyna Biernacka
Rok vydání: 2014
Předmět:
Adult
Heart Defects
Congenital

Male
medicine.medical_specialty
Cardiac Catheterization
Time Factors
Adolescent
medicine.medical_treatment
Hemodynamics
Young Adult
Oxygen Consumption
Double outlet right ventricle
Predictive Value of Tests
Internal medicine
medicine
Humans
Cardiac Surgical Procedures
Tetralogy of Fallot
Retrospective Studies
Heart Valve Prosthesis Implantation
Pulmonary Valve
Ejection fraction
Exercise Tolerance
business.industry
Ross procedure
Patient Selection
General Medicine
Recovery of Function
medicine.disease
Magnetic Resonance Imaging
Pulmonary Valve Insufficiency
Pulmonary Valve Stenosis
medicine.anatomical_structure
Treatment Outcome
Great arteries
Echocardiography
Pulmonary valve
Cardiology
Exercise Test
Female
Cardiology and Cardiovascular Medicine
Pulmonary atresia
business
Zdroj: Cardiology journal. 22(3)
ISSN: 1898-018X
Popis: Background: The aim of the study was to evaluate the role of cardiopulmonary exercise testing (CPET) parameters in assessing exercise capacity improvement after percutaneous pulmonary valve implantation (PPVI). Additionally, it aimed to determine if there are any baseline characteristics influencing that change. Methods and results: The study comprised 32 patients (mean age 26 ± 9); 53% males; diagnosis: tetralogy of Fallot (n = 18), pulmonary atresia (n = 6), Ross procedure (n = 4), other (transposition of great arteries, pulmonary stenosis, double outlet right ventricle, common arterial trunk type II — n = 4) who underwent successful PPVI due to right ventricular out­flow tract dysfunction (predominant pulmonary regurgitation — n = 17, predominant pulmo­nary stenosis — n = 15). Treadmill CPET was performed before and a year after PPVI along with clinical evaluation, cardiac magnetic resonance and transthoracic echocardiography. Twelve months post successful PPVI (pulmonary valve competence restoration and pulmonary gradient reduction from 58.8 ± 47.1 to 26.6 ± 10.8 mm Hg) there was a significant decrease in the ventilatory equivalent for CO2 at peak exercise (EQCO 2 ) (25.3 ± 3.3 to 24.3 ± 3.0, p = 0.04) and oxygen consumption at peak exercise (pVO2) (20.4 ± 5.0 to 22.6 ± 5.3 mL/kg/min, p = 0.04). Improved EQCO2 correlated with an increase in right and left ventricular ejection fraction (respectively R = –0.57, p = 0.002; R = –0.56, p = 0.002). In this study, no baseline factors that might affect improvement in exercise function were found. Conclusions: Successful PPVI leads to an improvement in exercise capacity and hemodynamic response to exercise. The correlation between the improvement in EQCO2 or peak VO2 and baseline characteristics was too weak to reliably identify the group of patients that will benefit from the procedure
Databáze: OpenAIRE